nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednicarbate—Megestrol acetate—PGR—ovarian cancer	0.0612	0.21	CrCbGaD
Prednicarbate—Medroxyprogesterone Acetate—PGR—ovarian cancer	0.0356	0.122	CrCbGaD
Prednicarbate—Fluticasone Propionate—PGR—ovarian cancer	0.0353	0.121	CrCbGaD
Prednicarbate—Betamethasone—PGR—ovarian cancer	0.0324	0.111	CrCbGaD
Prednicarbate—Secondary infection—Epirubicin—ovarian cancer	0.0301	0.0545	CcSEcCtD
Prednicarbate—Secondary infection—Doxorubicin—ovarian cancer	0.0278	0.0505	CcSEcCtD
Prednicarbate—Folliculitis—Paclitaxel—ovarian cancer	0.0246	0.0446	CcSEcCtD
Prednicarbate—Medroxyprogesterone Acetate—ESR1—ovarian cancer	0.0225	0.0772	CrCbGaD
Prednicarbate—Eruption—Docetaxel—ovarian cancer	0.0213	0.0386	CcSEcCtD
Prednicarbate—Infection—Carboplatin—ovarian cancer	0.0208	0.0377	CcSEcCtD
Prednicarbate—Leukoderma—Epirubicin—ovarian cancer	0.0208	0.0377	CcSEcCtD
Prednicarbate—Leukoderma—Doxorubicin—ovarian cancer	0.0193	0.0349	CcSEcCtD
Prednicarbate—Dexamethasone—PGR—ovarian cancer	0.0188	0.0646	CrCbGaD
Prednicarbate—Pain—Carboplatin—ovarian cancer	0.0179	0.0325	CcSEcCtD
Prednicarbate—Dexamethasone—CYP1B1—ovarian cancer	0.0176	0.0604	CrCbGaD
Prednicarbate—NR3C1—myometrium—ovarian cancer	0.0169	0.108	CbGeAlD
Prednicarbate—Megestrol acetate—ABCB1—ovarian cancer	0.0164	0.0563	CrCbGaD
Prednicarbate—NR3C1—embryo—ovarian cancer	0.0163	0.104	CbGeAlD
Prednicarbate—Eruption—Epirubicin—ovarian cancer	0.0144	0.0261	CcSEcCtD
Prednicarbate—Folliculitis—Epirubicin—ovarian cancer	0.0141	0.0255	CcSEcCtD
Prednicarbate—Eruption—Doxorubicin—ovarian cancer	0.0133	0.0241	CcSEcCtD
Prednicarbate—NR3C1—epithelium—ovarian cancer	0.0133	0.0847	CbGeAlD
Prednicarbate—NR3C1—uterine cervix—ovarian cancer	0.0132	0.0839	CbGeAlD
Prednicarbate—Folliculitis—Doxorubicin—ovarian cancer	0.013	0.0236	CcSEcCtD
Prednicarbate—Methylprednisolone—ABCB1—ovarian cancer	0.0126	0.0431	CrCbGaD
Prednicarbate—NR3C1—decidua—ovarian cancer	0.0125	0.08	CbGeAlD
Prednicarbate—NR3C1—endometrium—ovarian cancer	0.0119	0.0759	CbGeAlD
Prednicarbate—NR3C1—gonad—ovarian cancer	0.011	0.0704	CbGeAlD
Prednicarbate—NR3C1—uterus—ovarian cancer	0.011	0.07	CbGeAlD
Prednicarbate—Infection—Chlorambucil—ovarian cancer	0.0107	0.0194	CcSEcCtD
Prednicarbate—NR3C1—female reproductive system—ovarian cancer	0.00987	0.0629	CbGeAlD
Prednicarbate—Prednisone—ABCB1—ovarian cancer	0.00961	0.033	CrCbGaD
Prednicarbate—Infection—Topotecan—ovarian cancer	0.00953	0.0173	CcSEcCtD
Prednicarbate—Oedema—Melphalan—ovarian cancer	0.00939	0.017	CcSEcCtD
Prednicarbate—Infection—Melphalan—ovarian cancer	0.00933	0.0169	CcSEcCtD
Prednicarbate—NR3C1—bone marrow—ovarian cancer	0.00932	0.0594	CbGeAlD
Prednicarbate—Pain—Chlorambucil—ovarian cancer	0.00921	0.0167	CcSEcCtD
Prednicarbate—NR3C1—female gonad—ovarian cancer	0.00898	0.0572	CbGeAlD
Prednicarbate—NR3C1—vagina—ovarian cancer	0.00892	0.0569	CbGeAlD
Prednicarbate—Prednisolone—ABCB1—ovarian cancer	0.00886	0.0304	CrCbGaD
Prednicarbate—Dermatitis contact—Epirubicin—ovarian cancer	0.00874	0.0158	CcSEcCtD
Prednicarbate—Betamethasone—ABCB1—ovarian cancer	0.00868	0.0298	CrCbGaD
Prednicarbate—Paraesthesia—Topotecan—ovarian cancer	0.00861	0.0156	CcSEcCtD
Prednicarbate—Urticaria—Chlorambucil—ovarian cancer	0.00856	0.0155	CcSEcCtD
Prednicarbate—Paraesthesia—Melphalan—ovarian cancer	0.00843	0.0153	CcSEcCtD
Prednicarbate—Pain—Topotecan—ovarian cancer	0.0082	0.0149	CcSEcCtD
Prednicarbate—Infection—Vinorelbine—ovarian cancer	0.00815	0.0148	CcSEcCtD
Prednicarbate—Dermatitis contact—Doxorubicin—ovarian cancer	0.00809	0.0147	CcSEcCtD
Prednicarbate—Pain—Melphalan—ovarian cancer	0.00803	0.0146	CcSEcCtD
Prednicarbate—NR3C1—testis—ovarian cancer	0.00796	0.0508	CbGeAlD
Prednicarbate—Pruritus—Chlorambucil—ovarian cancer	0.00762	0.0138	CcSEcCtD
Prednicarbate—Urticaria—Topotecan—ovarian cancer	0.00762	0.0138	CcSEcCtD
Prednicarbate—Urticaria—Melphalan—ovarian cancer	0.00746	0.0135	CcSEcCtD
Prednicarbate—Paraesthesia—Vinorelbine—ovarian cancer	0.00737	0.0134	CcSEcCtD
Prednicarbate—Pain—Vinorelbine—ovarian cancer	0.00702	0.0127	CcSEcCtD
Prednicarbate—Pruritus—Topotecan—ovarian cancer	0.00679	0.0123	CcSEcCtD
Prednicarbate—Hydrocortisone—ABCB1—ovarian cancer	0.00678	0.0233	CrCbGaD
Prednicarbate—Pruritus—Melphalan—ovarian cancer	0.00665	0.012	CcSEcCtD
Prednicarbate—Urticaria—Vinorelbine—ovarian cancer	0.00652	0.0118	CcSEcCtD
Prednicarbate—Rash—Topotecan—ovarian cancer	0.00605	0.011	CcSEcCtD
Prednicarbate—Dermatitis—Topotecan—ovarian cancer	0.00604	0.011	CcSEcCtD
Prednicarbate—Rash—Melphalan—ovarian cancer	0.00592	0.0107	CcSEcCtD
Prednicarbate—Dermatitis—Melphalan—ovarian cancer	0.00592	0.0107	CcSEcCtD
Prednicarbate—Pruritus—Vinorelbine—ovarian cancer	0.00581	0.0105	CcSEcCtD
Prednicarbate—NR3C1—lymph node—ovarian cancer	0.00577	0.0368	CbGeAlD
Prednicarbate—Oedema—Paclitaxel—ovarian cancer	0.00552	0.01	CcSEcCtD
Prednicarbate—Infection—Paclitaxel—ovarian cancer	0.00548	0.00994	CcSEcCtD
Prednicarbate—Rash—Vinorelbine—ovarian cancer	0.00517	0.00938	CcSEcCtD
Prednicarbate—Dermatitis—Vinorelbine—ovarian cancer	0.00517	0.00937	CcSEcCtD
Prednicarbate—Dexamethasone—ABCB1—ovarian cancer	0.00505	0.0173	CrCbGaD
Prednicarbate—Paraesthesia—Paclitaxel—ovarian cancer	0.00496	0.00898	CcSEcCtD
Prednicarbate—Pain—Paclitaxel—ovarian cancer	0.00472	0.00855	CcSEcCtD
Prednicarbate—Oedema—Docetaxel—ovarian cancer	0.00468	0.00848	CcSEcCtD
Prednicarbate—Infection—Docetaxel—ovarian cancer	0.00465	0.00842	CcSEcCtD
Prednicarbate—Urticaria—Paclitaxel—ovarian cancer	0.00438	0.00795	CcSEcCtD
Prednicarbate—Paraesthesia—Docetaxel—ovarian cancer	0.0042	0.00761	CcSEcCtD
Prednicarbate—Pain—Docetaxel—ovarian cancer	0.004	0.00725	CcSEcCtD
Prednicarbate—Pruritus—Paclitaxel—ovarian cancer	0.00391	0.00708	CcSEcCtD
Prednicarbate—Rash—Paclitaxel—ovarian cancer	0.00348	0.00631	CcSEcCtD
Prednicarbate—Dermatitis—Paclitaxel—ovarian cancer	0.00348	0.0063	CcSEcCtD
Prednicarbate—Pruritus—Docetaxel—ovarian cancer	0.00331	0.006	CcSEcCtD
Prednicarbate—Oedema—Epirubicin—ovarian cancer	0.00316	0.00572	CcSEcCtD
Prednicarbate—Infection—Epirubicin—ovarian cancer	0.00313	0.00568	CcSEcCtD
Prednicarbate—Rash—Docetaxel—ovarian cancer	0.00295	0.00535	CcSEcCtD
Prednicarbate—Dermatitis—Docetaxel—ovarian cancer	0.00295	0.00534	CcSEcCtD
Prednicarbate—Oedema—Doxorubicin—ovarian cancer	0.00292	0.00529	CcSEcCtD
Prednicarbate—Infection—Doxorubicin—ovarian cancer	0.0029	0.00526	CcSEcCtD
Prednicarbate—Paraesthesia—Epirubicin—ovarian cancer	0.00283	0.00514	CcSEcCtD
Prednicarbate—Pain—Epirubicin—ovarian cancer	0.0027	0.00489	CcSEcCtD
Prednicarbate—Paraesthesia—Doxorubicin—ovarian cancer	0.00262	0.00475	CcSEcCtD
Prednicarbate—Urticaria—Epirubicin—ovarian cancer	0.00251	0.00454	CcSEcCtD
Prednicarbate—Pain—Doxorubicin—ovarian cancer	0.0025	0.00453	CcSEcCtD
Prednicarbate—Urticaria—Doxorubicin—ovarian cancer	0.00232	0.0042	CcSEcCtD
Prednicarbate—Pruritus—Epirubicin—ovarian cancer	0.00223	0.00405	CcSEcCtD
Prednicarbate—Pruritus—Doxorubicin—ovarian cancer	0.00207	0.00374	CcSEcCtD
Prednicarbate—Rash—Epirubicin—ovarian cancer	0.00199	0.00361	CcSEcCtD
Prednicarbate—Dermatitis—Epirubicin—ovarian cancer	0.00199	0.0036	CcSEcCtD
Prednicarbate—Rash—Doxorubicin—ovarian cancer	0.00184	0.00334	CcSEcCtD
Prednicarbate—Dermatitis—Doxorubicin—ovarian cancer	0.00184	0.00333	CcSEcCtD
